Can You Pay for Peptides or GLP-1s With an HSA or FSA?

A prescribed GLP-1 filled by a licensed pharmacy, yes. A vial bought from a research-peptide seller, no. What decides it is whether the purchase counts as a "prescribed drug" that was "legally procured," the two phrases the tax code uses for any medicine paid for with pre-tax money. Whether the drug works, or whether a doctor would approve of it, does not come into it. Brand Wegovy, Zepbound, Ozempic and Mounjaro pass. Compounded semaglutide or tirzepatide from a licensed compounding pharmacy on a valid prescription passes, with paperwork. Anything labelled "for research use only" fails on every test, and no letter from a doctor changes that. This page describes the federal rules as written. It is not tax advice; your plan administrator decides claims, and a tax professional can tell you how the rules apply to you. Updated 27 September 2026.

What does the IRS rule actually say?

Health savings accounts, flexible spending accounts and health reimbursement arrangements all reimburse "medical care" as defined in section 213 of the Internal Revenue Code. For medicines specifically, section 213(b) says an amount paid for a medicine or drug counts only if it is a prescribed drug or insulin, and section 213(d)(3) defines a prescribed drug as one that requires a prescription of a physician for its use by an individual.¹⁵ The Treasury regulations add two more conditions: the term "medicine and drugs" covers only items that are legally procured, and amounts spent on illegal operations or treatments are not deductible.¹ IRS Publication 502 puts the same rule in plain language. You can include amounts you pay for prescribed medicines and drugs, a prescribed drug being one that requires a prescription for its use, and in general you cannot include the cost of a drug ordered from another country because you can only include the cost of a drug that was imported legally.² So there are three tests, and a purchase has to pass all three:

1. The drug requires a prescription to be used.
2. You have a valid prescription from someone licensed to write one.
3. The drug was obtained legally: dispensed by a licensed pharmacy, not imported in breach of federal law, not marketed as something it is not.

Are Wegovy, Zepbound, Ozempic and Mounjaro HSA eligible?

Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and the oral semaglutide tablets are prescription drugs dispensed by licensed pharmacies. They pass all three tests. Your copay, or the full cash price if you pay out of pocket, is an eligible expense. Weight loss on its own is not a medical purpose, though. Publication 502 allows weight-loss expenses when they are treatment for a specific disease diagnosed by a physician, such as obesity, hypertension or heart disease.² IRS counsel has said the same about weight-loss medication: it can be medical care only if it is a prescribed drug, and only where obesity or another condition is the thing being treated.³ A prescription written for a diagnosed condition covers this. A prescription written so that someone with a normal BMI can lose a few pounds is the case an administrator can question.

Is compounded semaglutide or tirzepatide FSA or HSA eligible?

A compounded drug made by a licensed compounding pharmacy on a valid prescription is a prescribed drug. It requires a prescription, you have one, and a licensed pharmacy dispensed it. That satisfies section 213. The paperwork matters more here than with a brand product, for two reasons. First, compounding has been in flux; the compounded semaglutide guide covers the timeline. During the semaglutide and tirzepatide shortages, pharmacies could compound copies freely; after the FDA declared the shortages resolved, the rules for compounding "essentially a copy" of an approved drug tightened, and what a given pharmacy may lawfully make now depends on the prescription being for a patient-specific reason. Your administrator does not police this, but if an FSA claim is ever audited, the question will be whether the drug was legally procured, and the answer is the prescription and the pharmacy's licence. Second, compounded drugs often lack the product codes that let an HSA or FSA debit card approve a purchase automatically at checkout. Telehealth companies that bundle the visit and the drug into one charge run into this most. The card gets declined, and people read that as "not eligible." Usually it just means the merchant's system could not classify the charge. Pay another way, then submit a claim with three documents: the prescription, an itemised receipt from the pharmacy showing the drug and the amount, and the visit note or letter that names the diagnosis. Keep those three documents for every fill. Administrators can request them at any time and the IRS can request them for years afterward. One practical point for HSAs: you do not have to pay with the HSA card at the time. A qualified expense incurred after the account was opened can be reimbursed from the account later, in the same year or years afterward, as long as you kept the records. So a declined card at checkout changes nothing; pay by any method and reimburse yourself when the paperwork is in hand. FSAs are stricter, with plan-year deadlines for claims, so file those promptly.

Can you use an HSA or FSA for research peptides?

A vial sold as "for research use only" or "not for human consumption" fails all three tests at once. The seller is not selling it for use in a person, so it is not a drug that requires a prescription. No licensed prescriber can write a prescription for a product that is not a drug, so you cannot hold one. And the label itself says no medicine is being sold, so it was not legally procured as one. The FDA has said that selling unapproved retatrutide to consumers is illegal, and the same position applies to any unapproved compound sold for injection.⁴ Under the Treasury regulations, an illegally procured drug or an illegal treatment is not medical care, and how well it works has no bearing on that.¹ This is true for BPC-157, for a GLP-1 in a research vial, and for a compound that has an approved version elsewhere. The legal status guide explains why a research label is a statement about the seller, not the substance. The approved version being legal does not make the research vial legal. Two things people try that do not work:

• A letter of medical necessity. An LMN converts a dual-purpose item (a gym membership, a supplement) into a medical expense by tying it to a diagnosis. It cannot make an illegally procured drug legally procured, because the letter speaks to why you bought something and the test the research vial fails is how it was obtained.
• Paying the vendor with an HSA card. Some sellers' payment processors will accept the card. That tells you nothing about eligibility. The purchase is reimbursable only if it qualifies under section 213, and if it does not, the amount is taxable income plus, for an HSA, a 20% penalty on the non-qualified distribution.

Is a clinic-prescribed peptide like BPC-157 HSA eligible?

A prescription from a clinic for compounded BPC-157, TB-500, or another non-GLP-1 peptide is where people most often guess wrong. The prescription is real and the pharmacy is licensed, so the first two tests pass. The third one depends on the compound. A compounding pharmacy may lawfully compound a substance only if it is a component of an approved drug, has a USP monograph, or appears on the FDA's list of bulk substances that may be used in compounding. Most research peptides are none of those. BPC-157 was nominated for that list, withdrawn, and then backed by an advisory committee in July 2026, but the FDA has not added it; KPV, TB-500 and others sit in similar positions.⁶ If the pharmacy could not lawfully make the compound, the drug was not legally procured, and a prescription does not cure that. Before treating a clinic peptide as eligible, check where it stands on the FDA's compounding categories. The regulatory tracker lists every compound in the library by category and links the FDA documents.

Can you use an HSA for Ozempic from Canada or Mexico?

Ozempic from a Canadian pharmacy or a Mexican counter is the same molecule and often a third of the price. It is not an eligible expense. Publication 502 says you cannot include the cost of a prescribed drug brought in or ordered shipped from another country, because only a legally imported drug counts, and personal importation of prescription drugs is illegal under federal law in nearly every case.² The exception is a drug you bought and used while in the other country.

Are the visit, the syringes and the bloodwork eligible?

The telehealth or clinic visit where a licensed prescriber evaluates you is an eligible expense on its own, whether or not a drug is prescribed. A membership that bundles the visit with coaching, supplements or other non-medical extras is eligible only for the medical portion, and an administrator can ask you to split it; a provider that itemises the invoice saves you the argument. Syringes and needles are eligible when used to administer a prescribed drug. Bloodwork ordered by a prescriber is eligible. If you are weighing the cost of a prescribed route against a research vial, the cost guide has current figures for both. Bacteriostatic water bought from a research seller to mix a research vial is not, for the same reason the vial is not.

Common questions

Is compounded semaglutide FSA eligible?

Yes, when a licensed prescriber wrote the prescription for a diagnosed condition and a licensed compounding pharmacy dispensed it. Expect the debit card to decline at some telehealth checkouts; pay another way and file a claim with the prescription, the pharmacy receipt and the diagnosis.

Is compounded tirzepatide HSA eligible?

Same answer as compounded semaglutide: yes with a prescription for a diagnosed condition and a licensed compounding pharmacy, and keep the three documents. Zepbound and Mounjaro, the brand versions, are eligible without the extra paperwork.

Are peptides HSA eligible in general?

Only a peptide that is a prescribed drug, dispensed by a licensed pharmacy that may lawfully make or supply it. That covers the approved GLP-1s and lawfully compounded versions of them. It does not cover research-use vials or most clinic-prescribed compounds outside the FDA's compounding lists.

Can I use my HSA for peptides from a research website?

No. Research-use products are not prescribed drugs and are not legally procured as medicines, so they fail the section 213 test. Using HSA money for them is a non-qualified distribution: taxable, and penalised if you are under 65.

Does a letter of medical necessity make peptides HSA eligible?

No. A letter addresses whether a product has a medical purpose. It does not change whether the product was legally obtained, which is the test a research vial fails.

Why was my HSA card declined for a GLP-1 that is eligible?

Most often because the merchant's system could not code the compounded drug or the bundled telehealth charge as an eligible item. The decline says nothing about eligibility. Submit a manual claim.

Is Ozempic HSA eligible if I use it for weight loss and not diabetes?

The drug is a prescribed drug either way. The question an administrator may ask is whether it treats a diagnosed condition. Obesity is one; Publication 502 names it. Keep the diagnosis on file.

Can I use my HSA for BPC-157 a clinic prescribed?

Only if the pharmacy could lawfully compound it. For most research peptides it could not, or the question is unsettled. Check the compound's FDA compounding category on the regulatory tracker before treating the expense as eligible.

I bought brand Ozempic from a Canadian pharmacy. Is that eligible?

No. Drugs ordered from another country are excluded unless they were legally imported, and personal imports of prescription drugs are not.

What do I need to keep?

For every fill: the prescription, an itemised receipt showing the drug and the price, and the visit note or letter naming the diagnosis. For an HSA the record-keeping burden is yours, not the administrator's.

Sources

1. 26 U.S.C. § 213(b) and § 213(d)(3), https://www.law.cornell.edu/uscode/text/26/213 ; 26 CFR § 1.213-1(e)(2) (medicine and drugs include only items legally procured) and § 1.213-1(e)(1)(ii) (illegal operations or treatments), https://www.ecfr.gov/current/title-26/section-1.213-1
2. Internal Revenue Service, Publication 502, Medical and Dental Expenses: sections on Medicines, Weight-Loss Program, and Medicines and Drugs From Other Countries. https://www.irs.gov/publications/p502
3. Internal Revenue Service, Office of Chief Counsel, information letter 2001-0155 on the treatment of obesity as a disease and weight-loss medication as medical care. https://www.stayexempt.irs.gov/pub/irs-wd/01-0155.pdf
4. FDA statement of June 2026 on retatrutide sold to consumers, as reported by CNBC, 12 August 2026. https://www.cnbc.com/2026/08/12/lilly-lawsuits-obesity-drug-retatrutide.html
5. Internal Revenue Service, Office of Chief Counsel, information letter 2000-0080 on the prescribed-drug requirement. https://www.stayexempt.irs.gov/pub/irs-wd/00-0080.pdf
6. FDA, Bulk Drug Substances Nominated for Use in Compounding Under Section 503A (interim categories), and the July 23 to 24, 2026 Pharmacy Compounding Advisory Committee meeting materials, both linked from the regulatory tracker. https://peptidedecoding.com/status